Provided by Tiger Trade Technology Pte. Ltd.

Shattuck Labs, Inc.

6.84
+0.02000.29%
Volume:2.02M
Turnover:14.25M
Market Cap:686.48M
PE:-13.65
High:7.29
Open:6.95
Low:6.67
Close:6.82
52wk High:8.33
52wk Low:1.70
Shares:100.36M
Float Shares:67.76M
Volume Ratio:1.33
T/O Rate:2.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5010
EPS(LYR):-0.7014
ROE:-39.21%
ROA:-24.43%
PB:3.25
PE(LYR):-9.75

Loading ...

Wedbush Lifts Price Target on Shattuck Labs to $14 From $11, Keeps Outperform Rating

MT Newswires Live
·
Yesterday

Shattuck Labs (STTK) Receives a Buy from Leerink Partners

TIPRANKS
·
Yesterday

Shattuck Labs Plans Phase 2 Trial of Chronic Inflammatory Skin Disease Drug

MT Newswires Live
·
Yesterday

Shattuck Labs Names Shoba Ravichandran Senior Vice President, Clinical Development

Reuters
·
Yesterday

Shattuck Labs - Phase 2 Trial to Start in 2026; 16-Week Data Expected in H1 2028

THOMSON REUTERS
·
Yesterday

Shattuck Labs - Existing Cash Expected to Fund Operations into 2029

THOMSON REUTERS
·
Yesterday

Shattuck Labs - to Initiate Phase 2 Trial of Sl-325 in Hidradenitis Suppurativa

THOMSON REUTERS
·
Yesterday

Shattuck Labs - Ind Submission for Phase 2 Trial Expected in October 2026

THOMSON REUTERS
·
Yesterday

Shattuck Labs Announces Phase 2 Clinical Trial of Sl-325 in Hidradenitis Suppurativa and Appointment of Shoba Ravichandran, M.d., as Senior Vice President, Clinical Development

THOMSON REUTERS
·
Yesterday

Pantginis Maintains Buy on Shattuck as Merck TL1A/DR3 Data De-Risk SL-325; Price Target Reiterated at $14

TIPRANKS
·
Yesterday

Shattuck Labs management to meet with Piper Sandler

TIPRANKS
·
Sep 24

Shattuck Labs Announces Participation in Upcoming September Investor Conferences

GlobeNewswire
·
Sep 03

Raymond James Initiates Coverage on Shattuck Labs With Strong Buy Rating, $18 Price Target

MT Newswires Live
·
Aug 24

Shattuck Labs Inc : Raymond James Initiates Coverage with Strong Buy Rating; Target Price $18

THOMSON REUTERS
·
Aug 24

Shattuck Labs initiated with a Strong Buy at Raymond James

TIPRANKS
·
Aug 24

Shattuck Labs Advances SL-325 Crohn’s Trial Toward a Key Value Milestone

TIPRANKS
·
Aug 13

Wedbush Reaffirms Their Buy Rating on Shattuck Labs (STTK)

TIPRANKS
·
Aug 12

Shattuck Labs Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 12

Sutro Biopharma Q2 Revenue Misses Estimates, Posts Wider Loss

Reuters
·
Aug 12

Erasca Q2 Net Loss Widens on Higher R&D Costs

Reuters
·
Aug 12